Healthnostics, Inc. Retires 90 Million Outstanding Shares

NEW YORK, NY–(Marketwire – June 30, 2010) –  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, announced that in addition to its recent investment in a medical manufacturing company, it has invested in the repurchase of 90 million shares of its common stock in a private transaction, thereby reducing the actual issued and outstanding shares to 305,857,509. Of this total, the approximately 39 million shares which are not closely held are traded in the public market. These shares constitute the public float.

Both the investment in an ongoing acquisition and the investment in the repurchase of shares will have the immediate effect of increasing shareholder equity through significantly enhanced earnings per share.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.